A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects

por Darwish, Mona, Youakim, James M., Harlick, Jim, DeKarske, Daryl, Stankovic, Serge
Publicado 2022

Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study

por Darwish, Mona, Bugarski-Kirola, Dragana, Passarell, Julie, Owen, Joel, Jaworowicz, David, DeKarske, Daryl, Stankovic, Srdjan
Publicado 2022

An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson’s Disease and Depression

por DeKarske, Daryl, Alva, Gustavo, Aldred, Jason L., Coate, Bruce, Cantillon, Marc, Jacobi, Lori, Nunez, Rene, Norton, James C., Abler, Victor
Publicado 2020